HARD MEASURES OF SUBJECTIVE OUTCOMES - VALIDATING SYMPTOM INDEXES IN UROLOGY

被引:63
作者
OLEARY, MP
BARRY, MJ
FOWLER, FJ
机构
[1] MASSACHUSETTS GEN HOSP,MED SERV,BOSTON,MA 02114
[2] HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115
[3] UNIV MASSACHUSETTS,CTR SURVEY RES,AMHERST,MA 01003
关键词
UROLOGIC DISEASES; PROSTATIC HYPERTROPHY; PATIENT CARE PLANNING; DIAGNOSIS;
D O I
10.1016/S0022-5347(17)36965-3
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Scientifically validated (accurate), and reproducible (precise) methods of assessing the frequency and severity of patient symptoms are becoming more widely used in medicine. Such a symptom index has been developed for patients with benign prostatic hyperplasia, and may find use in clinical practice and research. The criteria for developing and validating such indexes are presented, using the new benign prostatic hyperplasia symptom index as an example. The same approach can be applied to many other disease entities in urology that demand a quantitation of the illness experience from the perspective of the patients.
引用
收藏
页码:1546 / 1548
页数:3
相关论文
共 14 条
[1]  
BARRY MJ, 1990, PROSTATE S, V3, P61
[2]  
Codman EA., 1914, SURG GYNECOL OBSTET, V18, P491
[3]  
Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297
[4]   ASSESSING THE RESPONSIVENESS OF FUNCTIONAL SCALES TO CLINICAL-CHANGE - AN ANALOGY TO DIAGNOSTIC-TEST PERFORMANCE [J].
DEYO, RA ;
CENTOR, RM .
JOURNAL OF CHRONIC DISEASES, 1986, 39 (11) :897-906
[5]   ON CLASSIFYING CANCERS WHILE TREATING PATIENTS [J].
FEINSTEIN, AR .
ARCHIVES OF INTERNAL MEDICINE, 1985, 145 (10) :1789-1791
[6]  
FOWLER FJ, 1984, SURVEY RES METHODS, P86
[7]   A METHODOLOGICAL FRAMEWORK FOR ASSESSING HEALTH INDEXES [J].
KIRSHNER, B ;
GUYATT, G .
JOURNAL OF CHRONIC DISEASES, 1985, 38 (01) :27-36
[8]   TRANS-URETHRAL PROSTATECTOMY - IMMEDIATE AND POSTOPERATIVE COMPLICATIONS - A COOPERATIVE STUDY OF 13 PARTICIPATING INSTITUTIONS EVALUATING 3,885 PATIENTS [J].
MEBUST, WK ;
HOLTGREWE, HL ;
COCKETT, ATK ;
PETERS, PC .
JOURNAL OF UROLOGY, 1989, 141 (02) :243-247
[9]  
MOR V, 1984, CANCER-AM CANCER SOC, V53, P2002, DOI 10.1002/1097-0142(19840501)53:9<2002::AID-CNCR2820530933>3.0.CO
[10]  
2-W